Home/Filings/4/0001192482-21-000188
4//SEC Filing

Murphy Peter C. 4

Accession 0001192482-21-000188

CIK 0001561921other

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 5:24 PM ET

Size

6.9 KB

Accession

0001192482-21-000188

Insider Transaction Report

Form 4
Period: 2021-02-24
Murphy Peter C.
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2021-02-24+11,20011,200 total
  • Award

    Stock Option (right to buy)

    2021-02-24+20,40020,400 total
    Exercise: $16.99Exp: 2031-02-24Common Stock (20,400 underlying)
Footnotes (2)
  • [F1]These restricted stock units will vest in four equal annual installments beginning on February 24, 2022, subject to the Reporting Person's continuous service with the Issuer.
  • [F2]The option vests 25% on February 24, 2022, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continuous service with the Issuer.

Issuer

TELA Bio, Inc.

CIK 0001561921

Entity typeother

Related Parties

1
  • filerCIK 0001801542

Filing Metadata

Form type
4
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 5:24 PM ET
Size
6.9 KB